πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 112 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9834587

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9814762

Targeted therapeutic proteins

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9796999

Detection of oligosaccharides

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9796664

Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9771408

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9572870

Delivery of therapeutic compounds to the brain and other tissues

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9567572

Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and us

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9540395

Histone deacetylase inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9512143

Histone deacetylase inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9504762

Adeno-associated virus factor VIII vectors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9469683

Lysosomal targeting peptides and uses thereof

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9433624

Methods and compositions for the treatment of metabolic disorders

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9376480

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9265734

Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9216178

Dry blend formulation of tetrahydrobiopterin

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9200264

Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses the

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9089566

Delivery of therapeutic compounds to the brain and other tissues

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9044473

Delivery of therapeutic compounds to the brain and other tissues

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9029530

Detection of oligosaccharides

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9018201

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in trea

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8999987

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8957066

Histone deacetylase inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8940513

Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and us

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8859498

Targeted therapeutic proteins

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted